riteaid is a company based out of 7189 henry clay blvd, liverpool, new york, united states.

Company profile
Ticker
RADCQ
Exchange
Website
CEO
Heyward Donigan
Employees
Incorporated
Location
Fiscal year end
Sector
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
1515 West State Street Boise, Idaho, LLC • 1740 Associates, LLC • 4042 Warrensville Center Road—Warrensville Ohio, Inc. • 5277 Associates, Inc. • 5600 Superior Properties, Inc. • Advance Benefits, LLC • Apex Drug Stores, Inc. • Ascend Health Technology, LLC • Broadview and Wallings—Broadview Heights Ohio, Inc. • Design Rx, LLC ...
IRS number
231614034
RADCQ stock data
Latest filings (excl ownership)
8-K
Entry into a Material Definitive Agreement
1 Nov 23
25-NSE
Exchange delisting
31 Oct 23
8-K
Rite Aid Corporation Appoints Jeffrey S. Stein Chief Executive Officer
19 Oct 23
10-Q
2024 Q2
Quarterly report
17 Oct 23
8-K/A
Reaches Agreement in Principle with Key Creditors on the Terms of Financial Restructuring Plan
16 Oct 23
8-K
Reaches Agreement in Principle with Key Creditors on the Terms of Financial Restructuring Plan
16 Oct 23
NT 10-Q
Notice of late quarterly filing
12 Oct 23
8-K
Rite Aid Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Standards
4 Oct 23
8-K
Submission of Matters to a Vote of Security Holders
24 Aug 23
8-K
Departure of Directors or Certain Officers
31 Jul 23
Transcripts
RADCQ
Earnings call transcript
2023 Q4
20 Apr 23
RADCQ
Earnings call transcript
2023 Q3
21 Dec 22
RADCQ
Earnings call transcript
2023 Q2
29 Sep 22
RADCQ
Earnings call transcript
2023 Q1
23 Jun 22
RADCQ
Earnings call transcript
2022 Q4
14 Apr 22
RADCQ
Earnings call transcript
2022 Q3
21 Dec 21
RADCQ
Earnings call transcript
2022 Q2
23 Sep 21
RADCQ
Earnings call transcript
2022 Q1
24 Jun 21
RADCQ
Earnings call transcript
2021 Q4
15 Apr 21
RADCQ
Earnings call transcript
2021 Q4
15 Apr 21
Latest ownership filings
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Nov 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Mar 23 | Feb 22 | Feb 21 | Feb 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 92.93 mm | 92.93 mm | 92.93 mm | 92.93 mm | 92.93 mm | 92.93 mm |
Cash burn (monthly) | 14.20 mm | (no burn) | 339.23 mm | 137.78 mm | 146.87 mm | 79.72 mm |
Cash used (since last report) | 43.88 mm | n/a | 1.05 bn | 425.76 mm | 453.88 mm | 246.36 mm |
Cash remaining | 49.04 mm | n/a | -955.39 mm | -332.84 mm | -360.95 mm | -153.43 mm |
Runway (months of cash) | 3.5 | n/a | -2.8 | -2.4 | -2.5 | -1.9 |
Institutional ownership, Q3 2023
29.4% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 99 |
Opened positions | 17 |
Closed positions | 28 |
Increased positions | 17 |
Reduced positions | 24 |
13F shares | Current |
---|---|
Total value | 6.82 bn |
Total shares | 16.60 mm |
Total puts | 8.83 mm |
Total calls | 2.63 mm |
Total put/call ratio | 3.4 |
Largest owners | Shares | Value |
---|---|---|
Charles Schwab Investment Management | 5.00 mm | $2.24 bn |
Vanguard | 2.90 mm | $1.30 bn |
GMT Capital | 1.48 mm | $663.98 mm |
BCS Barclays | 1.14 mm | $508.00 k |
BLK Blackrock | 1.02 mm | $458.23 mm |
Renaissance Technologies | 722.60 k | $330.68 mm |
Susquehanna International | 640.39 k | $286.90 mm |
Geode Capital Management | 540.04 k | $242.00 mm |
Silver Point Capital | 500.00 k | $224.00 mm |
STT State Street | 325.69 k | $145.91 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
27 Jul 23 | Kazmaier Jessica | Common Stock | Payment of exercise | Dispose F | No | No | 1.58 | 6,934 | 10.96 k | 89,794 |
27 Jul 23 | Schroeder Matt | Common Stock | Payment of exercise | Dispose F | No | No | 1.58 | 17,349 | 27.41 k | 195,781 |
27 Jul 23 | Mennen Justin L. | Common Stock | Payment of exercise | Dispose F | No | No | 1.58 | 4,968 | 7.85 k | 136,342 |
7 Jul 23 | Steven Bixler | Common Stock | Payment of exercise | Dispose F | No | No | 1.64 | 147 | 241.08 | 3,540 |
7 Jul 23 | Steven Bixler | Common Stock | Payment of exercise | Dispose F | No | No | 1.64 | 208 | 341.12 | 3,687 |
News
Drugstore Chain Rite Aid Counters DOJ Lawsuit Amid Bankruptcy, Aiming To Safeguard Restructuring
17 Nov 23
Could Your Eye Drops Be Unsafe? FDA Flags Amazon For Distributing Risky Eye Products, Demands Immediate Action
15 Nov 23
GSK's Competitive Edge, Surpasses Pfizer in Respiratory Syncytial Virus Vaccine Sales
30 Oct 23
'Pharmageddon' - Thousands Of Pharmacists Plan Walkout To Protest Work Conditions: Report
30 Oct 23
Risk of Eye Infection - FDA Issues Strong Warning on Eye Drops from Major Retailers
30 Oct 23
Press releases
Rite Aid Helps Customers Prioritize Immunity During Busy Holiday Season with Flu Shot Fridays
29 Nov 23
Rite Aid Pharmacists Now Have Prescriptive Authority for Hormonal Contraceptives in Five States
28 Nov 23
Rite Aid to Honor Military Service Members with Veteran Appreciation Discount
2 Nov 23
Rite Aid to Offer After Work Wednesday Walk-In Clinic
30 Oct 23
Rite Aid Receives Court Approval of "First Day" Motions to Support Business Operations
17 Oct 23